Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials.

CONCLUSION: Overall, PFS is an optimized IBSE in targeted therapies for glioblastoma; however, 12moPFS is optimal in antiangiogenic therapy. PMID: 32193895 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32193895?dopt=Abstract

Source: Korean J Radiol - March 21, 2020 Category: Radiology Authors: Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ, Kim KW Tags: Korean J Radiol Source Type: research

More News: Brain | Cancer & Oncology | Neurology | Radiology